The integrin adhesome and control of anti-tumour immunity
Biochemical Society Transactions · 2024
DOI: 10.1042/bst20240386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2024. Verfasst von Emily R Webb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, U.K. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Integrins, Cell Adhesion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust.
Abstract (Originalsprache)
It is widely regarded that the anti-tumour immune response drives clearance of tumours and leads to prolonged survival in patients. However, tumours are adept at reprogramming the surrounding microenvironment to an immunosuppressive milieu to prevent successful immune directed killing. Adhesion of cells to the extracellular matrix is essential for regulating cellular processes such as survival, proliferation and migration. This adhesion is largely conducted via integrins and their related intracellular signalling networks. Adhesion proteins such as focal adhesion kinase (FAK) are expressed in both tumour cells and cells of the surrounding microenvironment, and are often dysregulated in cancers. Recent work has demonstrated that adhesion proteins are contributing to regulation of the immunosuppressive microenvironment within tumours, and could provide a new avenue to target in combination with immunotherapies. Here, we provide an overview of the effort being made to elucidate the roles adhesion proteins play in modulating anti-tumour responses within a variety of cancer settings. In particular we focus on the multifaceted role of FAK within the tumour immune microenvironment. Finally, we summarise the data in clinical trials, where targeting FAK is being exploited to prime the tumour microenvironment and create potent responses when combined with immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, U.K.
ORCID-Profile: Valerie G Brunton
Förderung
- Cancer Research UK
- Wellcome Trust
Zitieren
APA
Webb, E. R., Black, A., Barth, N. D., Symeonides, S. N., & Brunton, V. G. (2024). The integrin adhesome and control of anti-tumour immunity. Biochemical Society Transactions. https://doi.org/10.1042/bst20240386
Vancouver
Webb ER, Black A, Barth ND, Symeonides SN, Brunton VG. The integrin adhesome and control of anti-tumour immunity. Biochemical Society Transactions. 2024. doi:10.1042/bst20240386
BibTeX
@article{Webb2024,
author = {Webb, Emily R and Black, Annabel and Barth, Nicole D and Symeonides, Stefan N and Brunton, Valerie G},
title = {The integrin adhesome and control of anti-tumour immunity},
journal = {Biochemical Society Transactions},
year = {2024},
doi = {10.1042/bst20240386}
}
EUVIMED